|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Earned premiums | |||||
| Other | |||||
| Total revenues | |||||
| Expenses: | |||||
| Medical expenses | |||||
| Selling, general, and administrative expenses | |||||
| Depreciation and amortization | |||||
| Total expenses | |||||
| Income (loss) from operations | |||||
| Other expenses: | |||||
| Other expenses (income) | |||||
| Interest expense | |||||
| Other income, net | |||||
| Loss on extinguishment of debt | |||||
| Total other expenses | |||||
| Loss before income taxes | |||||
| Total | |||||
| Net loss | |||||
| Less: Net loss attributable to noncontrolling interest | |||||
| Net loss attributable to Alignment Healthcare, Inc. | |||||
| Total weighted-average common shares outstanding - basic | |||||
| Total weighted-average common shares outstanding - basic (in shares) | |||||
| Total weighted-average common shares outstanding - diluted (in shares) | |||||
| Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share) | |||||
| Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share) | |||||
Loading...